Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.47 USD | -5.71% | -10.20% | -51.54% |
May. 15 | Sector Update: Health Care Stocks Advance in Afternoon Trading | MT |
May. 15 | CASI Pharmaceuticals Gets FDA Clearance For Blood Disorder Study | MT |
Financials (USD)
Sales 2024 * | 19.8M | Sales 2025 * | 46.48M | Capitalization | 45.07M |
---|---|---|---|---|---|
Net income 2024 * | -35M | Net income 2025 * | -33M | EV / Sales 2024 * | 2.28 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.97 x |
P/E ratio 2024 * |
-1.36
x | P/E ratio 2025 * |
-1.63
x | Employees | 176 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 50.99% |
1 day | -5.71% | ||
1 week | -10.20% | ||
Current month | -10.20% | ||
1 month | +32.29% | ||
3 months | -28.75% | ||
6 months | -50.71% | ||
Current year | -51.54% |
Managers | Title | Age | Since |
---|---|---|---|
Wei Wu He
CEO | Chief Executive Officer | 59 | 19-04-01 |
Wei Zhang
DFI | Director of Finance/CFO | 64 | 18-08-31 |
Chun Hua Wang
COO | Chief Operating Officer | 52 | 16-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Wei Wu He
CEO | Chief Executive Officer | 59 | 19-04-01 |
Yue Wu
BRD | Director/Board Member | 62 | 13-03-31 |
Zhen Bo Su
BRD | Director/Board Member | 48 | 23-03-20 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 3.47 | -5.71% | 10,454 |
24-06-06 | 3.68 | +4.84% | 9,368 |
24-06-05 | 3.51 | -1.68% | 33,929 |
24-06-04 | 3.57 | -4.29% | 14,109 |
24-06-03 | 3.73 | -3.47% | 39,665 |
Delayed Quote Nasdaq, June 07, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-51.54% | 45.07M | |
+45.82% | 765B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.94% | 248B | |
-1.51% | 219B | |
+11.30% | 216B | |
+5.90% | 164B | |
-0.73% | 162B |
- Stock Market
- Equities
- CASI Stock